How Steroids Impact C. Difficile
Steroids are commonly prescribed medications used to reduce inflammation for conditions ranging from asthma to inflammatory bowel disease (IBD). However, research shows that steroids may negatively impact C. difficile infection - an increasingly common and hazardous intestinal illness.
What is C. Difficile Infection?
C. difficile, often referred to as C. diff, is a type of bacteria that causes infectious diarrhea and colitis when allowed to multiply unchecked within the intestinal tract. Toxins from the rapidly growing bacterial population damage the lining of the colon, eliciting an inflammatory reaction with symptoms like:
- Watery diarrhea
- Cramping abdominal pain
- Fever
- Nausea
In severe cases, C. diff can progress to life-threatening infections like pseudomembranous colitis or toxic megacolon due to overwhelming colonic inflammation and necrosis.
C. Diff Risk Factors
Certain conditions that alter the normal gut microbiome increase vulnerability to C. diff overgrowth after exposure, including:
- Antibiotic use - reduces healthy intestinal bacteria competing with C. diff
- Hospitalization - increases exposure opportunities
- GI surgery
- Tube feeding
- Immunosuppressant medications
- Chemotherapy
- Inflammatory bowel diseases like ulcerative colitis or Crohn's disease
Steroids and Risk of C. Difficile Problems
Given their immunosuppressive effects, steroids like prednisone and hydrocortisone theoretically could promote overgrowth and toxicity of opportunistic pathogens like C. diff through several mechanisms:
Blunting Inflammatory Signals
Steroids broadly suppress the body's natural immune reaction against invading pathogens. However, inflammatory signals often appropriately alert the body to mount defenses against harmful organisms like C. diff to prevent their uncontrolled spread.
Slowing Regrowth of Beneficial Bacteria
The normal healthy gut contains a diverse array of helpful bacterial organisms that keep pathologic species like C. diff in check through competition. The regenerative process of these essential bacteria after antibiotic injury relies partially upon inflammation. Steroids can interfere with inflammation necessary for microbiome repopulation.
Altering Intestinal Lining Integrity
The protective barriers separating intestinal microbes from deeper body tissues maintain tight seals preventing systemic infection. Research shows steroids may negatively impact the strength of these barrier junctions, potentially enabling infecting bacteria access to the bloodstream.
Research Evidence on Steroid Risks with C. Difficile
Population studies have confirmed clinical suspicions that systemic steroid use correlates with poorer C. diff infection outcomes, including:
Higher Risk of Severe Disease
Multiple investigations have linked steroid administration with 2-3 fold increased likelihood of progressing from mild C. diff diarrhea to dangerously inflamed pseudomembranous colitis involving colonic rupturing.
Increased Recurrence Rates Post-Treatment
Up to 35% experience repeat C. diff infections after antibacterial treatment due to residual spores. Those on steroids during their initial bout face recurrence percentages exceeding 50% often requiring recurrent therapy.
Prolonged Shedding of Toxin
Analysis of hospital C. diff outbreaks revealed infected patients on steroids continued excreting toxins for 2-3 times longer versus non-steroid patients - increasing transmission opportunities.
Strategies to Reduce C. Diff Risk with Steroids
The known hazards of steroids coexisting with C. diff does not mean individuals requiring anti-inflammatory treatment cannot use them. However, efforts to minimize chances of complications are prudent through:
Avoiding Unnecessary Antibiotics
Prevent antibiotic overuse allowing healthy gut flora depletion. Request viral testing to confirm bacterial infections first when reasonable and opt for narrow spectrum agents targeting the confirmed culprit.
Prioritizing Alternative Anti-Inflammatories When Possible
Discuss options like NSAIDs or newer biologics that may provide enough inflammation control while posing less disruption of infection defenses than steroids.
Monitoring for C. Diff Signs
Watch for symptoms like >3 loose or watery stools daily, new abdominal pain, nausea and fever indicating potential C. diff needing evaluation via stool testing while on steroids.
Observing Contact + Hand Hygiene
Practice protective habits between healthcare exposures to avoid introduction of new C. diff strains. Wash hands thoroughly after patient contact and before eating.
Undergoing Microbiome Repletion Therapies
Probiotic, prebiotic or fecal transplant regimens may help counteract steroid-related microbiome disruption preventing C. diff domination.
Special Considerations in Inflammatory Bowel Disease
Patients with conditions like ulcerative colitis already carry higher baseline risk of C. diff infection. They also frequently require steroid courses to control symptomatic flares of colonic inflammation. Special vigilance for C. diff complications is vital in this population when steroids are utilized by:
Monitoring Symptom Changes
New onset abdominal pain, bloating, fever and >3 liquid stools daily may reflect infectious diarrhea superimposed on an IBD flare while on steroids - warranting stool testing.
Conducting Routine C. Diff Screening
Some IBD centers check C. diff toxin assays every 1-3 months in patients on steroids due to higher infection prevalence, allowing early detection and treatment if positive.
Using Second Line Immunosuppressants First
Newer biologic agents like infliximab, vedolizumab or tofacitinib may replace or reduce steroid requirements in IBD, minimizing risks from the synergy between steroids and C. diff.
Can Steroids Still Be Used in Active C. Diff Infection?
Ideally, steroids should be avoided when acute C. diff infection is confirmed given the risks outlined. However, for severe IBD flares with coexisting C. diff, steroids may still be utilized carefully if alternative treatments fail to control extreme colonic inflammation after weighing the following considerations:
Assessing Severity of Flare
Steroid side effects may be justified only in moderate-severe IBD flares with high complication risks themselves if not rapidly controlled.
Switching to Budesonide
This form impacts localized intestine inflammation versus whole-body suppression, potentially balancing IBD and C. diff risk during combination therapy.
Preventing Post-Infectious Flares
Some providers use brief post-infectious steroid courses to curb IBD flaring after antibiotics clear C. diff bugs to offset harm of later steroid exposures for flare control.
Planning Aggressive Recurrence Prevention
Vigilance with microbiome support protocols helps encourage healthy flora recovery protecting against repeat C. diff bouts after steroids end.
The Takeaway
Steroids like prednisone used to calm inflammation in numerous conditions from asthma to IBD can negatively impact the course of C. diff infection by suppressing the body's natural defenses against uncontrolled spread of these bacteria throughout the colon. Those on steroids who develop symptoms concerning for C. diff like >3 watery daily stools, new abdominal pain, nausea or fever should undergo prompt stool testing to allow early diagnosis and treatment if positive. Extra care must be taken to avoid and monitor for C. diff in higher risk patients needing steroids like those with ulcerative colitis or Crohn's disease. However, steroids may still be carefully employed short-term in such cases if alternative therapies fail to control dangerous bowel inflammation - provided vigilant recurrence prevention measures are enacted concurrently.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a healthcare professional before starting any new treatment regimen.
Add Comment